With the severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002, the middle
east respiratory syndrome CoV (MERS-CoV) in 2012 and the recently discovered SARS …

The current global health threat by the novel coronavirus disease 2019 (COVID-19) requires
an urgent deployment of advanced therapeutic options available. The role of …

The highly contagious coronavirus, which had already affected more than 2 million people in
210 countries, triggered a colossal economic crisis consequently resulting from measures …

The SARS-CoV-2 outbreak is the COVID-19 disease, which has caused massive health
devastation, prompting the World Health Organization to declare a worldwide health …

The high transmission rate and serious consequences of the unprecedented COVID-19
pandemic make it challenging and urgent to identify viral pathogens and understand their …

The newly emerged ribonucleic acid (RNA) enveloped human beta-coronavirus, severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused the COVID-19 …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is exponentially spreading
across the world, leading to an outbreak of serious viral pneumonia. Antiviral therapies …

Introduction The current COVID-19 pandemic caused by the SARS-CoV-2 virus demands
the development of strategies not only to detect or inactivate the virus, but to treat it …

Conclusion To date, there are no specific approved drugs for treating SARS-CoV-2, and
vaccines are under clinical trials. All efforts are welcome to combat the virus, and nanotech …

Viral-associated respiratory infectious diseases are one of the most prominent subsets of
respiratory failures, known as viral respiratory infections (VRI). VRIs are proceeded by an …